Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy
Crossref DOI link: https://doi.org/10.1007/s00520-017-3797-2
Published Online: 2017-06-28
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Przybylski, Daniel J.
Reeves, David J.
License valid from 2017-06-28
